FDA Approves DNA/BIIB Rituxan for Rheumatoid Arthritis

March 1, 2006 6:47 AM EST Send to a Friend
Late Tuesday, Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login